More on ABUS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+50.0% Growth)
- Ratings (7.8 Score)
- Holders

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Arbutus Biopharma (NQ:ABUS)
Delayed: 5.09 +0.01 (0.20%)
Prev. Close $5.08  
Open$5.05 
52 Wk High$5.88 
52 Wk Low$2.65 
Day High$5.10 
Day Low$5.05 
P/E N/A  
EPS$0.00 
Volume2,610,133 

Friends, Peers and Foes (?): ROIV, MRNA, BGS, BOX, CRWD (more...)

Aug 24, 2026 08:24 AM Form SC TO-I Arbutus Biopharma Corp Filed by: Arbutus Biopharma Corp
Aug 24, 2026 07:30 AM Arbutus Biopharma launches $230M Dutch auction tender offer
Aug 24, 2026 07:30 AM Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share
Aug 21, 2026 08:04 AM Form SC TO-C Arbutus Biopharma Corp Filed by: Arbutus Biopharma Corp
Aug 21, 2026 07:53 AM Form 8-K Arbutus Biopharma Corp For: Aug 21
Aug 21, 2026 07:30 AM Arbutus plans $230M share repurchase via Dutch auction tender offer
Aug 21, 2026 07:30 AM Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
Aug 12, 2026 03:02 PM Form SCHEDULE 13G/A Arbutus Biopharma Corp Filed by: MORGAN STANLEY
Aug 12, 2026 07:50 AM Arbutus Biopharma (ABUS) Reports In-Line Q2 EPS
Aug 12, 2026 07:32 AM Form 10-Q Arbutus Biopharma Corp For: Jun 30
View All Articles

Entities mentioned with ABUS

View All Entities